Evidence map›Paper›PMID 31826238›Full record

ArticleInvestigative ophthalmology & visual science2019

Deep Phenotyping of PDE6C-Associated Achromatopsia.

Michalis Georgiou, Anthony G Robson, Navjit Singh, Nikolas Pontikos, Thomas Kane, Nashila Hirji, Caterina Ripamonti, Tryfon Rotsos, Alfredo Dubra, Angelos Kalitzeos and 3 more

Open access · goldAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Single-Cell Transcriptomics onBiomedicines · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Structural and functional dynamics of human cone cGMP-phosphodiesterase important for photopic vision.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  11. Clinical and genetic features ofFrontiers in medicine · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Gene Therapy for Achromatopsia.International journal of molecular sciences · 2024
    Review
  17. Article
  18. A patient with albinism and retinitis pigmentosa, a case report.American journal of ophthalmology case reports · 2024
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Michalis GeorgiouUCL Institute of Ophthalmology, University College London, London, United Kingdom.
Anthony G RobsonUCL Institute of Ophthalmology, University College London, London, United Kingdom.
Navjit SinghUCL Institute of Ophthalmology, University College London, London, United Kingdom.
Nikolas PontikosUCL Institute of Ophthalmology, University College London, London, United Kingdom.
Thomas KaneUCL Institute of Ophthalmology, University College London, London, United Kingdom.
Nashila HirjiUCL Institute of Ophthalmology, University College London, London, United Kingdom.
Caterina RipamontiCambridge Research Systems Ltd., Kent, United Kingdom.
Tryfon RotsosFirst Division of Ophthalmology, National and Kapodistrian University of Athens, General Hospital of Athens, Athens, Greece.
Alfredo DubraDepartment of Ophthalmology, Stanford University, Palo Alto, California, United States.
Angelos KalitzeosUCL Institute of Ophthalmology, University College London, London, United Kingdom.
Andrew R WebsterUCL Institute of Ophthalmology, University College London, London, United Kingdom.
Joseph CarrollDepartment of Ophthalmology & Visual Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin, United States.
Michel MichaelidesUCL Institute of Ophthalmology, University College London, London, United Kingdom.
University College London · GBMoorfields Eye Hospital NHS Foundation Trust · GBMedical College of Wisconsin · USNational and Kapodistrian University of Athens · GRStanford University · US

Funding

Assessing Photoreceptor Structure and Function in Normal and Diseased RetinaeR01EY017607 · NEI · MEDICAL COLLEGE OF WISCONSIN · PI Joseph Carroll · 2008 to 2026
$8.3M
Stanford Vision Research CoreP30EY026877 · NEI · STANFORD UNIVERSITY · PI Jeffrey L Goldberg · 2017 to 2026
$8.0M
Platform Technologies for Microscopic Retinal Imaging: Development & TranslationU01EY025477 · NEI · STANFORD UNIVERSITY · PI DUBRA, ALFREDO · 2015 to 2019
$4.4M
Axially-resolved Spectroscopic Ophthalmic ImagingR01EY025231 · NEI · STANFORD UNIVERSITY · PI DUBRA, ALFREDO · 2015 to 2019
$1.9M
VISION RES LAB: HERPETIC KERATIC, CORE PIGMENT GENES, RETINITIS PIGMENTOSAC06RR016511 · NCRR · MEDICAL COLLEGE OF WISCONSIN · PI DUNN, MICHAEL J · 2002 to 2002
$1.4M
Development, Validation and Application of Metabolic Imaging in GlaucomaR01EY028287 · NEI · STANFORD UNIVERSITY · PI DUBRA, ALFREDO, GOLDBERG, JEFFREY L · 2017 to 2019
$1.1M
Department of HealthNCRR NIH HHS C06 RR016511NEI NIH HHS P30 EY026877NEI NIH HHS R01 EY017607NEI NIH HHS R01 EY025231NEI NIH HHS R01 EY028287NEI NIH HHS U01 EY025477Wellcome TrustWellcome Trust 099173/Z/12/Z
6 · The paper itself

Abstract

Purpose: To perform deep phenotyping of subjects with PDE6C achromatopsia and examine disease natural history. Methods: Eight subjects with disease-causing variants in PDE6C were assessed in detail, including clinical phenotype, best-corrected visual acuity, fundus autofluorescence, and optical coherence tomography. Six subjects also had confocal and nonconfocal adaptive optics scanning light ophthalmoscopy, axial length, international standard pattern and full-field electroretinography (ERG), short-wavelength flash (S-cone) ERGs, and color vision testing. Results: All subjects presented with early-onset nystagmus, decreased best-corrected visual acuity, light sensitivity, and severe color vision loss, and five of them had high myopia. We identified three novel disease-causing variants and provide phenotype data associated with nine variants for the first time. No subjects had foveal hypoplasia or residual ellipsoid zone (EZ) at the foveal center; one had an absent EZ, three had a hyporeflective zone, and four had outer retinal atrophy. The mean width of the central EZ lesion on optical coherence tomography at baseline was 1923 μm. The mean annual increase in EZ lesion size was 48.3 μm. Fundus autofluorescence revealed a central hypoautofluorescence with a surrounding ring of increased signal (n = 5). The mean hypoautofluorescent area at baseline was 3.33 mm2 and increased in size by a mean of 0.13 mm2/year. Nonconfocal adaptive optics scanning light ophthalmoscopy revealed residual foveal cones in only one of two cases. Full-field ERGs were consistent with severe generalized cone system dysfunction but with relative preservation of S-cone sensitivity. Conclusions: PDE6C retinopathy is a severe cone dysfunction syndrome often presenting as typical achromatopsia but without foveal hypoplasia. Myopia and slowly progressive maculopathy are common features. There are few (if any) residual foveal cones for intervention in older adults.

Indexed as

Visual AcuityAdolescentAdultChildColor VisionColor Vision DefectsCyclic Nucleotide Phosphodiesterases, Type 6ElectroretinographyEye ProteinsFemaleFollow-Up StudiesForecastingHumansMaleMiddle AgedOphthalmoscopyCyclic Nucleotide Phosphodiesterases, Type 6Eye ProteinsPDE6C protein, human

Identifiers

PMID31826238
PMCPMC6905659
OpenAlexW2994650794

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.